China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
Weibo Experienced a Surge in Advertising Revenue Worth USD 427 Mn in Q1 2022
On June 1, China’s leading social media platform Weibo released its annual financial statements for the first quarter of 2022. The company’s advertising revenue reached USD 427 million, up 10% year on year.
Jun 03, 2022 12:59 AM
Hong Kong IPO at a Glance: Weibo Corporation
The Twitter-like platform completed its secondary listing on December 8, 2021.
Dec 08, 2021 10:03 PM